VISUM PHARMA, INC. — Form D
VISUM PHARMA, INC. of STAMFORD, CT, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-13. The offering totals $300K, of which $50K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2023-09-13
- Form: D
- Accession: 0001883978-23-000001
- Industry: Pharmaceuticals
- Exemptions: 06b, 4a5
- Total offering: $300K
- Amount sold: $50K
- Remaining: $250K
- Minimum investment: $50K
- Investors: 1
- Date of first sale: 2023-09-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-492053
Issuer
- Name: VISUM PHARMA, INC.
- CIK: 0001883978
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 48 GURLEY ROAD, STAMFORD, CT, 06902
- Phone: 9146735570
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| John J Costantino | Director | Stamford, CT |
| William J Gedale | Director | Stamford, CT |
| Bernard J Peperstraete | Director | Stamford, CT |
| Peter J Vanderklish | Director | Stamford, CT |
| Alex J Cuomo | Executive Officer | Stamford, CT |
| William J Gedale | Executive Officer | Stamford, CT |
| Mark Smith | Executive Officer | Palo Alto, CA |
Other filings by this issuer (1)
More